tiprankstipranks
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market
Holding CADL?
Track your performance easily

Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?

257 Followers

Candel Therapeutics (CADL) Ownership Overview

22.78%3.68%6.29%4.19%63.06%
22.78% Insiders
6.29% Other Institutional Investors
4.19% ETFs
63.06% Public Companies and
Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 14.16% of the company’s stock is owned by Institutional Investors, 22.78% is owned by Insiders, and 63.06% is owned by Public Companies and Individual Investors.
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail, and individual investors. Approximately 9.97% of the company’s stock is owned by Institutional Investors, 22.78% is owned by Insiders, and 4.19% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 18, 2024
xxxxxxxxxxxxx
$7500000
Dec 03, 2024
xxxxxxxxxxxxx
$92784
Dec 03, 2024
xxxxxxxxxxxxx
$63404
Dec 03, 2024
Paul Peter Tak
Ceo,director
xxxxxxxxxxxxx
$222254

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,084,332Insider11.43%44,487,905
4,127,158Insider9.28%36,112,633
995,096Institution2.24%8,707,090
794,540Institution1.79%6,952,225
673,883Institution1.52%5,896,476
294,788Insider0.66%2,579,395
292,438Institution0.66%2,558,833
223,399Institution0.50%1,954,741
156,898Institution0.35%1,372,858
152,000Insider0.34%1,330,000

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
673,883Institution1.52%5,896,476
292,438Institution0.66%2,558,833
223,399Institution0.50%1,954,741
156,898Institution0.35%1,372,858
100,439Institution0.23%878,841
74,895Institution0.17%655,331
46,777Institution0.11%409,299
14,245Institution0.03%124,644
9,218Institution0.02%80,658
9,100Institution0.02%79,625

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
566,066Institution1.27%4,953,078
543,642Institution1.22%2,870,430
182,581Institution0.41%1,597,584
220,073Institution0.49%1,161,985
108,049Institution0.24%1,058,880
90,715Institution0.20%478,975
45,893Institution0.10%401,564
12,304Institution0.03%115,191
10,979Institution0.02%109,351
18,686Institution0.04%98,662

FAQ

Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 6.29% of the company's stock is held by institutional investors, 22.78% is held by insiders, and 63.06% is held by retail investors.
    What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 6.29% of Candel Therapeutics (CADL) stock is held by institutional investors.
      What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
      According to the latest TipRanks data, approximately 63.06% of Candel Therapeutics (CADL) stock is held by retail investors.
        Who owns the most shares of Candel Therapeutics (CADL)?
        Estuardo Aguilar-Cordova owns the most shares of Candel Therapeutics (CADL).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis